Case-control Study of Mesh-infection After a Size Tailored Hernia Repair With C-Qur V-Patch (Re-SITUP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01761708

Recruitment Status : Unknown

Verified January 2013 by Stijn De Sutter, Algemeen Ziekenhuis Maria Middelares.
Recruitment status was: Active, not recruiting

First Posted : January 7, 2013

Last Update Posted : January 7, 2013

Sponsor:

Information provided by (Responsible Party):

Stijn De Sutter, Algemeen Ziekenhuis Maria Middelares

Study Description

Brief Summary:

Ventral hernias, such as umbilical, epigastric and trocar-site hernias, are best repaired with abdominal wall reinforcement by mesh implantation. Mesh-devices using a dual-sided mesh technology have been developed for the specific indication of small ventral hernias; this technique is very attractive because the mesh can be introduced through a nearly invisible scar in the umbilicus. The dual layer of the mesh inhibits the formation of adhesions of the viscera to the mesh so, if wanted, it can be positioned in a intraperitoneal position. No literature is available on the adequate size of mesh needed to repair a hernia defect of an umbilical or epigastric hernia. Very small hernias are now often enlarged for repair with a large mesh device. Small hernias might benefit of repair with a small mesh device so no enlargement of the defect is necessary Larger hernias might benefit from a larger mesh size to have more overlap of the mesh beyond the hernia defect. The SITUP-trial was a prospective cohort study who was designed to explore the efficacy of C-QUR V-Patch of different sizes for the different sizes of hernia defects. The study was stopped prematurely because of the perception of an unacceptably high rate of mesh infection. This new study will retrospectively examine the incidence of mesh infection in all ventral hernias repaired with a C-QUR V-Patch. Collection of patient data was done using the Eura-HS registry.

Condition or disease	Intervention/treatment
Ventral Hernia Umbilical Hernia Epigastric Hernia Trocar-site Hernia	Procedure: primary ventral hernia repair with mesh

Study Design

Layout table for study information

Study Type :	Observational [Patient Registry]
Actual Enrollment :	57 participants
Observational Model:	Cohort
Time Perspective:	Prospective
Target Follow-Up Duration:	12 Months
Official Title:	Case-control Study of Mesh-infection After a Size Tailored Hernia Repair With C-Qur V-Patch
Study Start Date :	March 2012
Estimated Primary Completion Date :	August 2013
Estimated Study Completion Date :	August 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hernia

U.S. FDA Resources

Groups and Cohorts

Group/Cohort	Intervention/treatment
umbilical, epigastric and trocar-site hernia	Procedure: primary ventral hernia repair with mesh

Outcome Measures

Primary Outcome Measures :

mesh infection [ Time Frame: incidence over 12 months ]

Secondary Outcome Measures :

hernia recurrence rate [ Time Frame: incidence over 12 months ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information

Ages Eligible for Study:	18 Years to 80 Years (Adult, Older Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

community sample

Criteria

Inclusion Criteria:

all adult patients that are planned for surgical repair of a umbilical, epigastric or trocar-site hernia will be considered to enter the study.

Exclusion Criteria:

patients refusing to participate at the follow up visits pregnancy age < 18 years life expectancy less than 12 months emergency operations liver cirrhosis or ascites cancer patients concomitant surgery other than hernia repair

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01761708

Locations

Layout table for location information

Belgium
AZ Maria Middelares
Gent, Belgium, 9000

Sponsors and Collaborators

Algemeen Ziekenhuis Maria Middelares

Investigators

Layout table for investigator information

Principal Investigator:	Stijn De Sutter, MD	Algemeen Ziekenhuis Maria Middelares
Study Director:	Filip Muysoms, MD	Algemeen Ziekenhuis Maria Middelares
Study Chair:	Iris Kyle-Leinhase, PhD	Algemeen Ziekenhuis Maria Middelares

More Information

Additional Information:

Layout table for additonal information

Responsible Party:	Stijn De Sutter, Dr. Stijn De Sutter, Algemeen Ziekenhuis Maria Middelares
ClinicalTrials.gov Identifier:	NCT01761708 History of Changes
Other Study ID Numbers:	Re-situp
First Posted:	January 7, 2013 Key Record Dates
Last Update Posted:	January 7, 2013
Last Verified:	January 2013

Keywords provided by Stijn De Sutter, Algemeen Ziekenhuis Maria Middelares:


primary ventral hernia repair with mesh umbilical hernia repair epigastric hernia repair C-Qur V-patch Size tailored repair	preperitoneal repair abdominal hernia dual sided mesh trocar-site hernia

Additional relevant MeSH terms:

Layout table for MeSH terms

Hernia, Umbilical Hernia Hernia, Ventral	Pathological Conditions, Anatomical Hernia, Abdominal Infant, Newborn, Diseases

To Top